Rights, sharing, and embargo policies

Cell Press supports responsible sharing. We recognize that authors want to share their papers and we encourage this. Find out how you can share your paper here: www.elsevier.com/sharing-articles.

There are, however, some differences between Elsevier's general policies and those of Cell Press. Most Cell Press articles are under a press embargo until the article is published because we generate substantial media coverage for relevant articles. We therefore discourage authors of press-embargoed articles from posting their accepted manuscripts on a personal homepage or blog prior to publication. For articles that are not under a press embargo, such postings are allowed.

We are happy to consider manuscripts previously posted on preprint servers such as arXiv, bioRxiv, BioRN, ChiRxiv, ChiRN, or SSRN. Some of our journals, including Cell Genomics, Cell Reports, Current Biology, and iScience, also support direct submission of manuscripts from bioRxiv and/or medRxiv via transfer of manuscript files and metadata to the journal's Editorial Manager site. Our support for posting of preprints only applies to the original submitted version of the manuscript; we do not support posting to preprint servers revisions that respond to editorial input and peer review or final accepted manuscripts. Once your paper is published, we encourage you to update the preprint record with a link to the final published article. Please see our prepublication publicity policies for more information on sharing your work at the prepublication stage.

Manuscripts are considered for publication with the understanding that no part of the work has been published previously in print or electronic format and the paper is not under consideration by another publication or electronic medium. Upon official acceptance of a manuscript, authors will be asked to complete a "Journal Publishing Agreement." To complete this step, we will send an email to the corresponding author confirming receipt of the manuscript together with a "Journal Publishing Agreement" form or a link to the online version of this agreement. For open access articles, authors retain copyright of their work, which is published under a Creative Commons license. Please see more details in the table below, and do not hesitate to contact your journal team if you have any questions whatsoever.

For authors submitting from January 2021 onwards all Cell Press journals offer an open access publishing option. We have a range of journals that are either full open access, where all articles are published on an open access basis, or hybrid open access, which offer a choice between subscription and open access publishing.

Authors of papers published by Cell Press can share their accepted manuscript (the post-peer-review version that does not incorporate copy editing and proofing) via non-commercial hosting platforms, such as their institutional repository, after a posting embargo period has elapsed (this is distinct from the press embargo mentioned above). The posting embargo period begins with the publication date of the issue in which the article appears. For open access articles, authors may post the accepted manuscript as soon as the article is published in a journal issue. For articles published on a subscription basis, authors may deposit the accepted manuscript once the relevant journal posting embargo period (see below) has passed.

The table below shows the posting embargo periods for Cell Press journals as well as the relevant open access fees for new submissions as of January 1, 2021.

Cell Press open access and hybrid research journals support open access publication for groups of authors from Research4Life (R4L) countries. For papers where all of the authors are from a Group A and/or Group B R4L country we will grant a waiver or discount of the standard publishing fee, as appropriate. For fully open access journals the R4L eligibility check will be automatic. For hybrid journals please highlight your situation to the journal team during the submission process so we can adjust accordingly.

If authors from other countries find the publishing fee associated with an open access journal challenging to cover and can show that this is because of a lack of research funding, we will consider individual reduction and waiver requests on a case-by-case basis.

If you have any questions about these provisions please contact us at [email protected] for more information.

Learn more about publishing open access at Cell Press here.